IGC Pharma (IGC) Shares Outstanding (2010 - 2026)
IGC Pharma (IGC) posted quarterly Shares Outstanding (Entity) of $98.8 million for Q1 2026, up 22.15% year-over-year from $80.9 million in Q1 2025, and up 3.95% quarter-over-quarter from $95.0 million in Q4 2025.
IGC Pharma (IGC) Shares Outstanding (2010 - 2026) Analysis & Trends
IGC Pharma (IGC) has reported Shares Outstanding (Entity) for 17 consecutive years, with $98.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 22.15% year-over-year to $98.8 million; the TTM figure through Mar 2026 stood at $98.8 million (up 22.15% YoY), while the FY2026 annual figure was $98.8 million, up 22.15% from the prior year.
- Shares Outstanding (Entity) climbed to $98.8 million in Q1 2026 per IGC's latest filing, from $95.0 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $98.8 million in Q1 2026 and bottomed at $51.1 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $70.0 million across 5 years, with a median of $66.7 million in 2024.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) climbed 2.39% — and 2024, when it surged 42.5%.
- IGC Pharma's Shares Outstanding (Entity) stood at $53.1 million in 2022, then rose by 20.08% to $63.7 million in 2023, then rose by 22.7% to $78.2 million in 2024, then increased by 21.53% to $95.0 million in 2025, then gained by 3.95% to $98.8 million in 2026.
- Business Quant data shows IGC's Shares Outstanding (Entity) at $98.8 million in Q1 2026, $95.0 million in Q4 2025, and $92.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | IGC Pharma | 30.17 Mn | 29.90 Mn | - | 98.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.16 Mn |
| Dec 31, 2025 | 90.46 Mn |
| Sep 30, 2025 | 90.46 Mn |
| Jun 30, 2025 | 83.03 Mn |
| Mar 31, 2025 | 79.66 Mn |
| Dec 31, 2024 | 77.63 Mn |
| Sep 30, 2024 | 76.01 Mn |
| Jun 30, 2024 | 72.81 Mn |
| Mar 31, 2024 | 58.84 Mn |
| Dec 31, 2023 | 63.73 Mn |
| Sep 30, 2023 | 54.30 Mn |
| Jun 30, 2023 | 53.08 Mn |
| Mar 31, 2023 | 52.58 Mn |
| Dec 31, 2022 | 53.06 Mn |
| Sep 30, 2022 | 52.19 Mn |
| Jun 30, 2022 | 51.62 Mn |
| Mar 31, 2022 | 49.99 Mn |
| Dec 31, 2021 | 51.05 Mn |
| Sep 30, 2021 | 49.95 Mn |
| Jun 30, 2021 | 47.91 Mn |